Related Experiment Video
Updated: Apr 24, 2026

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
Published on: July 7, 2023
Machine Learning Meets Pharmacokinetics: A Comparative Analysis of Predictive Models for Plasma Concentration-Time
Felix Jost1, Clemens Giegerich2, Christoph Grebner3
1Translational Medicine Unit, Quantitative Pharmacology, Research Pharmacometrics, Sanofi R&D, Frankfurt, Germany.
Abstract:
Predicting pharmacokinetic (PK) profiles from molecular structures represents a significant advancement in pharmaceutical research with substantial implications for expediting drug discovery processes. We evaluated five approaches to systematically compare five distinct methodological frameworks for predicting rat plasma concentration-time profiles directly from molecular structures using a consistent dataset and evaluation framework: (1) NCA-ML, predicted non-compartmental analysis parameters with one compartmental PK modeling; (2) PBPK-ML, utilizing ML-predicted in vitro characteristics in physiologically based PK models; (3) CMT-ML, neural networks predicting compartmental PK model parameters with two or three compartmental PK modeling; (4) CMT-PINN, employing physics-informed neural networks trained on concentration-time profiles predicting compartmental PK model parameters with two or three compartmental PK modeling; and (5) PURE-ML, using decision trees to predict concentration values at specific time points. The CMT-PINN approach achieved highest predictive performance closely followed by PURE-ML (R2-log: 0.854 vs. 0.789, Spearman: 0.933 vs. 0.896), with 65.9% versus 61.0% of predictions within a twofold error of the observed concentrations. The other three approaches showed substantially lower performance metrices and higher prediction error margins. Models trained directly on concentration-time profiles outperformed those trained using derived PK parameters, particularly with limited training datasets. Our findings confirm the viability of predicting PK behavior from molecular structures prior to synthesis. The implementation of these computational approaches enables informed compound selection early in discovery, concentrating resources on promising candidates, and potentially reducing animal studies while accelerating development timelines.
Related Concept Videos
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Model Approaches for Pharmacokinetic Data: Physiological Models
